Screener
BioCryst Pharmaceuticals BCRX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ deficit: | ||
| Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 255,265 at June 30, 2026 and 213,060 at December 31, 2025 | 2,553 | 2,131 |
| Additional paid-in capital | 1,693,282 | 1,384,857 |
| Accumulated other comprehensive (loss) income | (528) | 38 |
| Accumulated deficit | (2,149,596) | (1,506,179) |
| Total stockholders’ deficit | (454,289) | (119,153) |
| Total liabilities and stockholders’ deficit | $557,851 | $514,158 |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's total liabilities & equity?
- BioCryst Pharmaceuticals (BCRX) reported total liabilities & equity of $557.85M in Q2 2026.
- How has BioCryst Pharmaceuticals's total liabilities & equity changed year-over-year?
- BioCryst Pharmaceuticals's total liabilities & equity increased by 22.0% year-over-year, from $457.19M to $557.85M.
- What is the long-term trend for BioCryst Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's total liabilities & equity has grown at a 9.0% compound annual growth rate (CAGR), from $334.72M to $514.16M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about BioCryst Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude